LifeSignals Group

LifeSignals Group develops wireless patient monitoring systems based on proprietary System-on-Chip technology and disposable biosensors. The company manufactures clinical-grade wearable devices that capture continuous vital signs including 2-channel ECG across hospital, hospital-at-home, and ambulatory care settings. Their technology platform was developed in collaboration with UC Berkeley's Wireless Research Center and co-founded by the inventor of Texas Instruments' TMS320 DSP chip.

The company's UbiqVue product family includes multiparameter monitoring systems for wireless hospitals and virtual wards, plus Holter ECG solutions for ambulatory cardiac services. Their biosensors utilize Wi-Fi-centric radio technology designed to maintain reliable connections for multiple patients in close proximity. Manufacturing partnerships with STMicroelectronics and Dreamtech enable production at scale while meeting clinical-grade requirements and regulatory compliance standards.

LifeSignals operates with engineering teams distributed across California and Bangalore, India, supported by medical advisors from Stanford Healthcare and UCSF. The company has deployed solutions with NHS Trust for inherited heart condition research and enabled mobile cardiac telemetry expansion in the United States market.

Organizations should consider LifeSignals when seeking a vertically integrated wireless monitoring solution that includes both the biosensor hardware and supporting software infrastructure. The company's semiconductor expertise and manufacturing partnerships position them to deliver cost-effective disposable biosensors at population health scale.

Expect engagement models centered on system integration and partnership rather than component sales. The platform is most valuable for organizations planning significant wireless monitoring deployments across hospital or home care settings where their end-to-end approach can streamline implementation compared to assembling multiple vendors.

LifeSignals exclusively serves healthcare markets with HIPAA and GDPR-compliant wireless monitoring systems. The company specializes in three primary verticals: in-hospital wireless monitoring for acute care settings, hospital-at-home solutions enabling remote patient monitoring with hospital-grade data quality, and ambulatory cardiac services including Holter ECG and mobile cardiac telemetry. Their medical and regulatory operations team manages clinical trials, worldwide regulatory clearances, and quality assurance to meet medical device requirements across global markets.

Health systems implementing wireless hospital initiatives or hospital-at-home programs requiring continuous vital signs monitoring for large patient populations. Cardiac monitoring service providers seeking scalable Holter and mobile cardiac telemetry solutions. Digital health companies and AI healthcare platforms needing clinical-grade biosensor infrastructure to support their services and analytics capabilities.